Patents by Inventor Saori MIYANO

Saori MIYANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS
    Publication number: 20230330081
    Abstract: Provided is a pharmaceutical composition for treating a tumor, comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxyl-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or its pharmaceutically acceptable salt, which is to be administered in combination with a PD-1 antagonist.
    Type: Application
    Filed: October 26, 2021
    Publication date: October 19, 2023
    Inventors: Taisuke HOSHI, Yu KATO, Yoichi OZAWA, Satoshi KAWANO, Kotaro KODAMA, Saori MIYANO
  • THERAPEUTIC AGENT FOR BREAST CANCER
    Publication number: 20230172924
    Abstract: Disclosed is a therapeutic agent for breast cancer, said therapeutic agent comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof that is to be administered in combination with an estrogen receptor antagonist or an aromatase inhibitor.
    Type: Application
    Filed: July 29, 2021
    Publication date: June 8, 2023
    Inventors: Satoshi KAWANO, Saori Miyano, Kyoko NISHIBATA, Sayo FUKUSHIMA
  • BREAST CANCER THERAPEUTIC AGENT
    Publication number: 20230149381
    Abstract: Provided is a therapeutic agent for treating breast cancer that has developed resistance to administration of CDK4/6 inhibitors and estrogen antagonists, the agent containing 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethox y)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: April 15, 2021
    Publication date: May 18, 2023
    Inventors: Kyoko NISHIBATA, Sayo FUKUSHIMA, Satoshi KAWANO, Saori MIYANO
  • Therapeutic agent for hepatocellular carcinoma
    Patent number: 11219619
    Abstract: Disclosed is a therapeutic agent for hepatocellular carcinoma, comprising 5-((2-(4-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: January 11, 2022
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Atsumi Yamaguchi, Hajime Shimizu, Satoshi Goda, Saori Miyano
  • BIOMARKERS FOR A THERAPY COMPRISING A SORAFENIB COMPOUND
    Publication number: 20210333281
    Abstract: Biomarkers are provided that predict whether a subject having a hepatocellular carcinoma is responsive to a therapy comprising soratenib or a pharmaceutically acceptable salt thereof. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for and treating a subject having, suspected of having, or at risk of developing a hepatocellular carcinoma.
    Type: Application
    Filed: October 2, 2019
    Publication date: October 28, 2021
    Inventors: Yasuhiro Funahashi, Yukinori Minoshima, Michio Kanekiyo, Saori Miyano, Taisuke Hoshi
  • THERAPEUTIC AGENT FOR HEPATOCELLULAR CARCINOMA
    Publication number: 20200375970
    Abstract: Disclosed is a therapeutic agent for hepatocellular carcinoma, comprising 5-((2-(4-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: March 26, 2019
    Publication date: December 3, 2020
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Atsumi Yamaguchi, Hajime Shimizu, Satoshi Goda, Saori Miyano
  • THERAPEUTIC AGENT FOR BILE DUCT CANCER
    Publication number: 20190111043
    Abstract: The present invention provides a therapeutic agent for bile duct cancer comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: December 19, 2018
    Publication date: April 18, 2019
    Applicants: NATIONAL CANCER CENTER, Eisai R&D Management Co., Ltd.
    Inventors: Tatsuhiro SHIBATA, Yasuhito ARAI, Kenichi NOMOTO, Tomio NAKAMURA, Akihiko TSURUOKA, Saori MIYANO
  • THERAPEUTIC AGENT FOR BREAST CANCER
    Publication number: 20180303817
    Abstract: The present application discloses a therapeutic agent for breast cancer, comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: December 15, 2016
    Publication date: October 25, 2018
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Saori Miyano, Yuji Yamamoto, Takayuki Nakagawa
  • THERAPEUTIC AGENT FOR BILE DUCT CANCER
    Publication number: 20180015079
    Abstract: The present invention provides a therapeutic agent for bile duct cancer comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: March 23, 2016
    Publication date: January 18, 2018
    Inventors: Tatsuhiro SHIBATA, Yasuhito ARAI, Kenichi NOMOTO, Tomio NAKAMURA, Akihiko TSURUOKA, Saori MIYANO